Advertisement

Topics

Real-World Study Confirms Lower Brain Bleed Risk with Dabigatran (CME/CE)

13:30 EST 13 Nov 2017 | MedPageToday

(MedPage Today) -- Findings from post-marketing surveillance similar to clinical trial data

Original Article: Real-World Study Confirms Lower Brain Bleed Risk with Dabigatran (CME/CE)

NEXT ARTICLE

More From BioPortfolio on "Real-World Study Confirms Lower Brain Bleed Risk with Dabigatran (CME/CE)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...